Skip to main content
Top
Published in: Breast Cancer 2/2010

01-04-2010 | Case Report

Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary gland

Authors: Hiroshi Takeyama, Hiroyuki Takahashi, Isao Tabei, Osamu Fukuchi, Hiroko Nogi, Satoki Kinoshita, Ken Uchida, Toshiaki Morikawa

Published in: Breast Cancer | Issue 2/2010

Login to get access

Abstract

A 58-year-old Japanese male patient visited our hospital for evaluation of an elastic hard mass, measuring 80 × 50 mm, in the right axillary area. Incisional biopsy for suspected malignancy was performed, and histopathologic examination by hematoxylin–eosin (H&E) staining yielded a diagnosis of poorly differentiated adenocarcinoma metastatic from an unknown primary. As the tumor was immunohistochemically positive for both ER and PgR, metastatic breast cancer was strongly suspected. Ultrasonography, CT, and MRI revealed no evidence of tumors in the bilateral mammary glands. Detailed examination of the head and neck region, lung, and upper and lower gastrointestinal tract also revealed no evidence of a primary tumor. After chemotherapy, the patient underwent tumor resection with axillary lymph node dissection. On the basis of the histological features of H&E-stained specimens and immunohistochemistry of the resected tumor, this case was diagnosed as breast cancer of unknown origin in a male. The tumor could have been an axillary lymph node metastasis from an occult breast carcinoma, or primary cancer arising in an accessory mammary gland.
Literature
1.
go back to reference Kemeny MM, Rivera DE, Terz JJ, Benfield JR. Occult primary adenocarcinoma with axillary metastases. Am J Surg. 1986;152:43–7.CrossRefPubMed Kemeny MM, Rivera DE, Terz JJ, Benfield JR. Occult primary adenocarcinoma with axillary metastases. Am J Surg. 1986;152:43–7.CrossRefPubMed
2.
go back to reference Osborne MP. Breast development and anatomy. In: Harris JR, Lippman ME, Morrow M, Hellmas S, editors. Disease of the breast. Philadelphia: Lippincott–Raven; 1996. p. 1–14. Osborne MP. Breast development and anatomy. In: Harris JR, Lippman ME, Morrow M, Hellmas S, editors. Disease of the breast. Philadelphia: Lippincott–Raven; 1996. p. 1–14.
3.
go back to reference Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, et al. Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J Natl Cancer Inst. 2004;96:1388–96.PubMedCrossRef Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, et al. Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J Natl Cancer Inst. 2004;96:1388–96.PubMedCrossRef
4.
go back to reference Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol. 1999;12:786–93.PubMed Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol. 1999;12:786–93.PubMed
5.
go back to reference Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, et al. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. Mod Pathol. 1994;7:37–43.PubMed Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, et al. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. Mod Pathol. 1994;7:37–43.PubMed
6.
go back to reference Riumshin GI, Rakitin IaA. Malignant accessory mammary gland tumor in man; rare case. Vopr Onkol. 1957;3:358–9. (in Russian).PubMed Riumshin GI, Rakitin IaA. Malignant accessory mammary gland tumor in man; rare case. Vopr Onkol. 1957;3:358–9. (in Russian).PubMed
7.
go back to reference Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.CrossRefPubMed Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.CrossRefPubMed
8.
go back to reference Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol. 2002;15:853–61.CrossRefPubMed Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, et al. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol. 2002;15:853–61.CrossRefPubMed
Metadata
Title
Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary gland
Authors
Hiroshi Takeyama
Hiroyuki Takahashi
Isao Tabei
Osamu Fukuchi
Hiroko Nogi
Satoki Kinoshita
Ken Uchida
Toshiaki Morikawa
Publication date
01-04-2010
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2010
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-009-0098-8

Other articles of this Issue 2/2010

Breast Cancer 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine